A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

por Janzic, Urska, Bidovec-Stojkovic, Urska, Korosec, Peter, Mohorcic, Katja, Mrak, Loredana, Caks, Marina, Ravnik, Maja, Skof, Erik, Rijavec, Matija
Publicado 2023

Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination

por Janzic, Urska, Bidovec-Stojkovic, Urska, Mohorcic, Katja, Mrak, Loredana, Dovnik, Nina Fokter, Ivanovic, Marija, Ravnik, Maja, Caks, Marina, Skof, Erik, Debeljak, Jerneja, Korosec, Peter, Rijavec, Matija
Publicado 2022